Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Med J Malaysia ; 63(2): 131-6, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18942299

RESUMEN

CT angiography (CTA) is a fast examination performed with a time-optimised contrast injection to enhance the cerebral arteries. Being a new imaging modality in our hospital, evaluation of the effectiveness of 64-row multislice CTA in detecting intracranial aneurysms in ruptured subarachnoid haemorrhage (SAH) cases is necessary. We conducted a descriptive prospective study by recruiting 30 consecutively operated SAH cases from May 2005 until November 2006. CTA findings were studied by radiologist and neurosurgeon and these were compared with operative findings. The sensitivity and specificity of CTA were 94.4% and 97.2% respectively. Approximately half of the patients were scanned within four hours and operated within 24 hours. In conclusion, CTA proves to be highly sensitive and specific in the diagnosis of intracranial aneurysms in our study.


Asunto(s)
Angiografía/métodos , Aneurisma Intracraneal/diagnóstico por imagen , Hemorragia Subaracnoidea/complicaciones , Tomografía Computarizada por Rayos X/métodos , Enfermedad Aguda , Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad
2.
Eye (Lond) ; 32(2): 324-332, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28862254

RESUMEN

PurposeTo report the efficacy, safety profile, and postoperative management of XEN45 implant at 12-month follow-up.Patients and methodsThis was a retrospective, non-randomised interventional case series involving patients who underwent XEN45 implantation by a single, experienced glaucoma specialist in a tertiary centre. Primary outcome measures were the intraocular pressure (IOP) and the number of medications at 1-year follow-up visit. Two IOP criteria were chosen to measure success: IOP ≤21 mm Hg and ≥20% reduction from baseline (criteria one); and IOP ≤15 mm Hg and ≥30% reduction from baseline (criteria two).ResultsAll 39 eyes completed 1-year follow-up. The mean preoperative IOP was 24.9±7.8 mm Hg on three drops, which reduced to 14.5±3.4 mm Hg at month 12 (P<0.005) on 0.7 drops (P<0.005). On the basis of criteria one, the cumulative probability of success at 1 year was 87.0% without medication and 92.0% with medication. On the basis of criteria two, cumulative probability of success was 62.0% without medication and 64.0% with medication. Bleb intervention with a median of 2 (range 1-4) was required for 51.3% of eyes. Implant was obstructed by iris tissue in three eyes (7.7%); one eye (2.6%) developed hyphaema; eight eyes (20.5%) had numerical hypotony (IOP≤5 mm Hg) at day 1, of which all spontaneously resolved by week 4 apart from one eye.ConclusionsThe XEN45 implant proved to be an effective treatment with a good safety profile at 1-year follow-up period. The high rate of postoperative bleb intervention does not make XEN45 a 'fit-and-forget' procedure and therefore the procedure should ideally be performed by surgeons experienced in bleb management.


Asunto(s)
Implantes de Drenaje de Glaucoma , Glaucoma/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Antihipertensivos/uso terapéutico , Femenino , Estudios de Seguimiento , Glaucoma/fisiopatología , Implantes de Drenaje de Glaucoma/efectos adversos , Humanos , Presión Intraocular/fisiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Agudeza Visual/fisiología
3.
Eye (Lond) ; 31(8): 1229-1236, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28452995

RESUMEN

PurposeTo investigate the frequencies, trends, and in vitro drug susceptibilities of the causative pathogens in microbial keratitis in Manchester Royal Eye Hospital.Patients and methodsCorneal scrape results recorded by the microbiology service between 2004 and 2015 were extracted from an established database. A total of 4229 corneal scrape specimens were identified from an established database. First-line antibiotic treatment in our centre during the study period was ofloxacin and second line was cefuroxime and gentamicin.ResultsMean age was 45.9±21.0. A total of 1379 samples (32.6%) were culture positive. One hundred forty-eight (10.7%) specimens cultured multiple organisms. Of the 1539 organisms identified, 63.3% were Gram-positive bacteria, 27.3% Gram-negative bacteria, 7.1% fungi, and 2.3% Acanthamoebae. A decreasing trend in Gram-positive isolates was found together with a stable trend in Gram negatives and an increasing trend in Acanthamoeba and fungi. There appeared to be a significant increasing trend of Moraxella infection (P=0.001). In all, 83.1 and 90.8% of Gram-positive and -negative isolates tested were susceptible to ofloxacin, respectively. Cefuroxime covered 86.6% of Gram-positive and 61.4% of Gram-negative isolates, whereas gentamicin covered 88.8 and 96.5% of Gram-positive and -negative isolates, respectively.ConclusionWe found a change in the type of Gram-negative organisms isolated over time, with the Moraxella species on the rise. Reassuringly, no significant increase in resistance was observed in vitro for any of the commonly used antibiotics. Ofloxacin remains a good first-line antibiotic treatment but duo-therapy does have broader coverage and should be considered in non-responsive cases.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Bacterianas del Ojo/microbiología , Queratitis/microbiología , Acanthamoeba/aislamiento & purificación , Adulto , Anciano , Antibacterianos/farmacología , Úlcera de la Córnea/microbiología , Farmacorresistencia Bacteriana/efectos de los fármacos , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Femenino , Hongos/aislamiento & purificación , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/aislamiento & purificación , Bacterias Grampositivas/efectos de los fármacos , Bacterias Grampositivas/aislamiento & purificación , Humanos , Queratitis/tratamiento farmacológico , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Retrospectivos , Centros de Atención Terciaria/estadística & datos numéricos , Reino Unido
4.
Leukemia ; 31(1): 1-10, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27389053

RESUMEN

Partial tandem duplication of MLL (MLL-PTD) characterizes acute myeloid leukemia (AML) patients often with a poor prognosis. To understand the order of occurrence of MLL-PTD in relation to other major AML mutations and to identify novel mutations that may be present in this unique AML molecular subtype, exome and targeted sequencing was performed on 85 MLL-PTD AML samples using HiSeq-2000. Genes involved in the cohesin complex (STAG2), a splicing factor (U2AF1) and a poorly studied gene, MGA were recurrently mutated, whereas NPM1, one of the most frequently mutated AML gene, was not mutated in MLL-PTD patients. Interestingly, clonality analysis suggests that IDH2/1, DNMT3A, U2AF1 and TET2 mutations are clonal and occur early, and MLL-PTD likely arises after these initial mutations. Conversely, proliferative mutations (FLT3, RAS), typically appear later, are largely subclonal and tend to be unstable. This study provides important insights for understanding the relative importance of different mutations for defining a targeted therapeutic strategy for MLL-PTD AML patients.


Asunto(s)
N-Metiltransferasa de Histona-Lisina/genética , Leucemia Mieloide Aguda/genética , Mutación , Proteína de la Leucemia Mieloide-Linfoide/genética , Proliferación Celular/genética , Células Clonales , Exoma , Humanos , Tasa de Mutación , Nucleofosmina , Secuencias Repetidas en Tándem , Factores de Tiempo
5.
Eye (Lond) ; 30(10): 1365-1370, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27391937

RESUMEN

PurposeTo evaluate the safety, efficacy, and the cost of combined phacoemulsification and single iStent insertion in open angle glaucoma (OAG) at 3-years follow-up.MethodsThis was a prospective, uncontrolled, interventional case series. All subjects underwent single iStent implantation combined with cataract surgery by a single surgeon and were followed up over 3 years. Primary outcome measures were the reduction in intraocular pressure (IOP) and number of glaucoma drops at 1, 2, and 3 years. The costs of the procedure vs the cost of continuation of glaucoma drops were calculated and compared in patients who completed 3-years follow-up.ResultsForty-one patients were included in the study and thirty-six patients completed 3-years follow-up. Mean pre-op IOP was 21.2 mm Hg on 2.1 medications. Mean IOP was reduced to 15.9 mm Hg on 0.5 drops, 16.1 mm Hg on 1.0 drops, and 17.1 mm Hg (P<0.001) on 1.3 drops (P<0.001) at 1, 2, and 3 years, respectively. The overall cost of combined cataract surgery and iStent was estimated to be £829.32 more in total than conservative management with brand name eye drops over 3 years (£7.70 per patient per year) and £14 176.9 more if generic drops were used. (£131.3 per patient per year).ConclusionsCombined phaco-iStent proved to be a safe and effective way of managing patients with OAG over our 3-year follow-up period. The cost-effectiveness of the procedure may vary depending on whether brand name or generic eye drops are used.


Asunto(s)
Costos y Análisis de Costo , Implantes de Drenaje de Glaucoma/economía , Glaucoma de Ángulo Abierto/economía , Facoemulsificación/economía , Anciano , Anciano de 80 o más Años , Antihipertensivos/economía , Antihipertensivos/uso terapéutico , Terapia Combinada , Costos de los Medicamentos , Femenino , Estudios de Seguimiento , Glaucoma de Ángulo Abierto/fisiopatología , Glaucoma de Ángulo Abierto/cirugía , Humanos , Presión Intraocular/fisiología , Implantación de Lentes Intraoculares/economía , Masculino , Estudios Prospectivos , Implantación de Prótesis , Stents/economía , Tonometría Ocular , Resultado del Tratamiento , Agudeza Visual/fisiología
6.
Eye (Lond) ; 30(6): 773-83, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26987591

RESUMEN

Metabolomics is the study of endogenous and exogenous metabolites in biological systems, which aims to provide comparative semi-quantitative information about all metabolites in the system. Metabolomics is an emerging and potentially powerful tool in ophthalmology research. It is therefore important for health professionals and researchers involved in the speciality to understand the basic principles of metabolomics experiments. This article provides an overview of the experimental workflow and examples of its use in ophthalmology research from the study of disease metabolism and pathogenesis to identification of biomarkers.


Asunto(s)
Investigación Biomédica , Metabolómica/métodos , Oftalmología/métodos , Animales , Biomarcadores , Humanos
9.
Ann N Y Acad Sci ; 1150: 263-6, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19120309

RESUMEN

This study aimed to investigate whether carboxypeptidase-H antibody (CPH-Ab) can help identify latent autoimmune diabetes in adults (LADA). Phenotypic type 2 diabetic (T2D) patients (n= 1296) were studied for CPH Abs and autoantibodies to glutamic acid decarboxylase (GAD-Abs). CPH-Ab(+) T2D patients also underwent testing for insulinoma protein tyrosine phosphatase (IA-2A). Clinical features were compared among CPH-Ab(+), GAD-Ab(+), and Ab(-) T2D patients. Some of the antibody-positive patients were followed up for 3 years to assess beta cell function. The prevalence of CPH-Abs in T2D patients was 4.8%, significantly higher than that in controls. Double positivity was rare between CPH-Abs and GAD-Abs or IA-2A. Compared to patients with Ab(-) T2D, those with CPH-Ab(+) T2D had lower BMI, lower fasting C-peptide (FCP) levels, and more frequent ketosis, while not as much as did those with GAD-Ab(+) T2D. The mild beta cell dysfunction in patients with CPH-Ab(+) T2D was associated with their longer duration of diabetes. No marked change of C-peptide in the CPH-Ab(+) group was found during follow-up. These findings demonstrated that CPH-Abs may allow discrimination of a more latent subset of adult-onset autoimmune diabetes (LADA) whose features are intermediate between those with classic GAD-Ab(+) LADA and patients with Ab(-) T2D.


Asunto(s)
Autoanticuerpos/sangre , Carboxipeptidasa H/inmunología , Diabetes Mellitus Tipo 1/diagnóstico , Diabetes Mellitus Tipo 2/diagnóstico , Adulto , Edad de Inicio , Anciano , Autoanticuerpos/fisiología , Estudios de Casos y Controles , China/epidemiología , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/epidemiología , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/inmunología , Diagnóstico Diferencial , Femenino , Estudios de Seguimiento , Humanos , Islotes Pancreáticos/fisiología , Masculino , Persona de Mediana Edad , Fenotipo , Estudios Seroepidemiológicos
10.
Sci Sin ; 24(12): 1143-52, 1981 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6977844

RESUMEN

Mice irradiated continuously at a low dose rate of 70 rad/day showed not only a drop of CFU-S content in the bone marrow but also an apparent functional disturbance of haemopoietic stem cells. With increase in accumulated dose of radiation, the damage of the haemopoietic microenvironment becomes evident. From the changes caused by chronical irradiation, it is believed that haemopoietic stem cells is more sensitive than haemopoietic microenvironment, and the radiation injury by hemopoiesis involves both damage of haemopoietic stem cells and microenvironment. Furthermore, in the course of recovery of hemopoietic injury, microenvironment plays as important role. In comparison of the growth curves of CFU-S from normal and irradiated bone marrow cells in irradiated recipient spleens or cultured in diffusion chambers, it is suggested that the nature of radiation damage of haemopoietic stem cells in continuous irradiation at low dose rate is mainly attributed to the deterioration of self replicative capacity of CFU-S.


Asunto(s)
Células Madre Hematopoyéticas/efectos de la radiación , Animales , División Celular/efectos de la radiación , Células Cultivadas , Ensayo de Unidades Formadoras de Colonias , Factores Estimulantes de Colonias/metabolismo , Activación Enzimática/efectos de la radiación , Femenino , Rayos gamma , Células Madre Hematopoyéticas/citología , Cinética , Masculino , Dosis de Radiación , Bazo/efectos de la radiación
11.
Skeletal Radiol ; 23(3): 187-90, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8016669

RESUMEN

The typical giant cell tumor (GCT) is a solitary neoplams that occurs in the epiphysis or epimetaphysis of long bones. GCT is seen with a slightly increased frequency in females, and 70% of patients are between 20 and 40 years of age at the time of presentation. Multicentric giant cell tumor (MGCT; two or more centers) is an unusual variant of GCT. Patients with MGCT are likely to be younger than those with a solitary lesion. The multicentric variety is often of a higher stage at diagnosis and is more often associated with a pathological fracture than the unifocal tumor. We are reporting five new cases of MGCT, with a total of 21 tumors seen over a period of 25 years from 1967 to 1992.


Asunto(s)
Neoplasias Óseas/patología , Tumor Óseo de Células Gigantes/patología , Adolescente , Adulto , Calcáneo/patología , Niño , Femenino , Neoplasias Femorales/patología , Peroné/patología , Dedos/patología , Humanos , Húmero/patología , Masculino , Recurrencia Local de Neoplasia/patología , Huesos Pélvicos/patología , Radio (Anatomía)/patología , Tibia/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA